Found 16 matching trials
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis PHASE3 The objective of this study is to evaluate the long-term safety of IDP-118 ...
Show More Learn More & Join Trial
A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis PHASE4 The objectives of this research are to demonstrate the following:1. To demo...
Show More Location
Dermatology Consulting Services, PLLC
Learn More & Join Trial
A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 PHASE1 Subjects with a clinical diagnosis of plaque psoriasis with 10% to 20% of b...
Show More Location
Dow Clinical Study Site
Learn More & Join Trial
Duobrii Treatment of Acne Keloidalis Nuchae (AKN) PHASE3 Acne keloidalis nuchae (AKN) is one of the chronic forms of scarring follic...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis PHASE2 Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis...
Learn More & Join Trial
A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis. EARLY_PHASE1 To evaluate the therapeutic equivalence and safety of halobetasol propionat...
Show More Location
Catawba Research, LLC
Learn More & Join Trial
Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults PHASE3 This study seeks to evaluate the safety, tolerability, and efficacy of topi...
Show More Location
Austin Institute for Clinical Research, Inc.
Learn More & Join Trial
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis PHASE4 This study is to evaluate the safety, the systemic exposure, and the hypoth...
Show More Learn More & Join Trial
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis PHASE3 Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis...
Learn More & Join Trial
Duobrii in Combination With Biologics PHASE4 12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic the...
Show More Location
Psoriasis Treatment Center of Central New Jersey
Learn More & Join Trial